Medical Imaging and Visualization TechnologyPathology & Diagnostics
Medical Enterprise SaaS
Technology Focus
AIATELLA transforms cardiovascular diagnostics by harnessing AI to automate quantification, detection, and interpretation of medical images across multiple imaging modalities. Their technology boosts efficiency, ensures standardized analysis, and enables precision medicine, addressing the global challenges of radiologist shortages and the rising burden of cardiovascular diseases.
AIATELLA transforms cardiovascular diagnostics by harnessing AI to automate quantification, detection, and interpretation of medical images across multiple imaging modalities. Their technology boosts efficiency, ensures standardized analysis, and enables precision...
Bioanalytical DevicesDrug Discovery and Development
AI Precision Medicine
Technology Focus
Mursla Bio is a UK and Boston-based AI precision diagnostics company pioneering organ-specific blood tests through extracellular vesicle (EV) science. Spun out of Cambridge University, Mursla is a world leader in translational EV research and has developed a proprietary platform to isolate and characterize EVs from specific organs directly from blood.
Mursla Bio is a UK and Boston-based AI precision diagnostics company pioneering organ-specific blood tests through extracellular vesicle (EV) science. Spun out of Cambridge University, Mursla is a world leader...
Drug Discovery and DevelopmentMedical Imaging and Visualization Technology
Imaginostics is creating the next generation of precision medicine diagnostic and prognostic tools.
Technology Focus
Imaginostics is creating the next generation of precision medicine diagnostic and prognostic tools to serve clinicians and drug developers to transform personalized healthcare, accelerate drug development, and fight aging. Our proprietary MRI physics-based technology delivers 10X better vascular images and quantitative measurements for vascular structure, function, and leakage.
Imaginostics is creating the next generation of precision medicine diagnostic and prognostic tools to serve clinicians and drug developers to transform personalized healthcare, accelerate drug development, and fight aging. Our...
Drug Discovery and DevelopmentPharmaceuticals Packaging
Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines.
Technology Focus
Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines. Its platform integrates advanced computational approaches and machine learning to discover and pharmacologically target new binding pockets on proteins that make them accessible to small-molecule drug discovery and development.
Frontier Medicines is a biopharmaceutical company that develops a chemoproteomics platform to accelerate the development of medicines. Its platform integrates advanced computational approaches and machine learning to discover and pharmacologically...
Fyllo is an IoT and AI based precision agriculture service company.
Technology Focus
Fyllo combines field devices, farm-level data, crop intelligence, and mobile advisories to guide irrigation, nutrition, disease control, and weather-related decisions.
Fyllo combines field devices, farm-level data, crop intelligence, and mobile advisories to guide irrigation, nutrition, disease control, and weather-related decisions.
Fasal is an AI-powered IoT-SaaS platform for horticulture that simplifies the process of cultivating crops.
Technology Focus
FasalOne combines field sensors, microclimate data, crop models, and AI advisories; FasalJet and FasalJet Pro automate irrigation and fertigation based on field conditions.
FasalOne combines field sensors, microclimate data, crop models, and AI advisories; FasalJet and FasalJet Pro automate irrigation and fertigation based on field conditions.
Oxylus Energy develops innovative carbon utilization technology, converting captured CO2 into carbon-neutral e-fuels and green chemical feedstocks like e-methanol. Our...
Oxylus Energy develops innovative carbon utilization technology, converting captured CO2 into carbon-neutral e-fuels and green chemical feedstocks like e-methanol. Our proprietary electrolysis, powered by renewable electricity, enables a circular carbon economy to decarbonize hard-to-abate industries such as shipping and aviation, with the potential to reduce up to 1 gigaton of CO2 emissions. Our patent-pending catalyst ensures high efficiency and cost-effective e-methanol production.
Rushnu revolutionizes heavy industry by converting captured CO₂ emissions into valuable green chemicals using its CarbonCatalyze™ system. This on-site, modular...
Rushnu revolutionizes heavy industry by converting captured CO₂ emissions into valuable green chemicals using its CarbonCatalyze™ system. This on-site, modular technology improves supply chain efficiency, enhances safety, and drives sustainable, economically viable chemical production, targeting a $65 billion market and eliminating 500 million tons of CO₂.
JCCL develops innovative, low-cost CO₂ capture and recycling technologies, including amine-containing gel absorbents and membrane coating fluids. Our patented solutions...
JCCL develops innovative, low-cost CO₂ capture and recycling technologies, including amine-containing gel absorbents and membrane coating fluids. Our patented solutions efficiently separate CO₂ from various sources with over 97% purity, reducing emissions and driving a sustainable, low-carbon future.
Cascade is a developer of enzyme immobilization kits designed to improve the sustainability and efficiency of existing processes of chemical...
Cascade is a developer of enzyme immobilization kits designed to improve the sustainability and efficiency of existing processes of chemical manufacturing
